Dr. Purushothaman Kuppan, Canada
Co-localized immune protection using cyclosporine A eluting micelles in a murine islet allograft model

Dr. Dario Gerace, United States
Engineering immune-evasive human stem cell derived-islet cells

Dr. Valentina Zamarian, Italy
Treating iPSC-derived β cells with monoclonal antibody Brentuximab reduces the risk of teratoma upon transplantation

Dr. Paraish Misra, Canada
Characterizing the therapeutic potential of human pluripotent stem cell-derived islet-like cells lacking cell-surface HLA expression

Dr. Yasaman Aghazadeh, Canada
Microvessels support the in vivo engraftment and function of pancreatic cells in cell replacement therapy

Dr. David A Alagpulinsa, United States
Long-term functional survival of human stem cell-derived islets microencapsulated in alginate with CXCL12 in non-human primates without immunosuppression

Dr. Sara D Sackett, United States
An inducible genome engineering approach for preventing immune rejection of hESC-derived beta cells

Ms. Jacqueline Burke, United States
Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability